Weight loss medication benefits patients with heart failure, obesity: Research
According to new research presented at the ESC Congress 2023, semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared to placebo in patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Read further on Dynamite News:
Dynamite News ·